US Stock MarketDetailed Quotes
SER Serina Therapeutics
- 8.830
- -0.405-4.39%
Close May 15 16:00 ET
74.29MMarket Cap-147166P/E (TTM)
9.290High8.662Low23.71KVolume8.662Open9.235Pre Close214.23KTurnover0.78%Turnover RatioLossP/E (Static)8.41MShares35.17052wk High-17.25P/B26.80MFloat Cap8.00052wk Low--Dividend TTM3.04MShs Float209.262Historical High--Div YieldTTM6.80%Amplitude8.000Historical Low9.034Avg Price1Lot Size
About Serina Therapeutics Company
Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.
Company Profile
SymbolSER
Company NameSerina Therapeutics
Listing DateNov 29, 2018
Founded2024
CEOMr. Steven Ledger
MarketAMEX
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address601 Genome Way,Suite 2001
CityHuntsville
ProvinceAlabama
CountryUnited States of America
Zip Code35806
Phone1-256-327-9630
Company Executives
- Name
- Position
- Salary
- Steven Ledger
- Director and Interim Chief Executive Officer
- --
- Andrea E. Park
- Interim Chief Financial Officer and Chief Accounting Officer
- --
- Dr. Randall W. Moreadith,M.D.,PhD
- Chief Scientific Officer
- --
- Dr. Tacey Viegas, PhD
- Chief Operating Officer and Secretary
- --
- Dr. Simba Gill, PhD
- Chairman of the Board
- --
- Steven M. Mintz
- Independent Director
- --
- J. Milton Harris, PhD
- Independent Director
- --
- Remy Gross
- Independent Director
- --
- Dr. Richard Marshall, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
